• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by IM Cannabis Corp.

    2/16/22 11:52:12 AM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $IMCC alert in real time by email
    SC 13G 1 formsc13g.htm FORM SC 13G IM Cannabis Corp.: Form SC 13G - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

    INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    IM CANNABIS CORP.

    (Name of Issuer)

    Common Shares, no par value

    (Title of Class of Securities)

    44969Q208

    (CUSIP Number)


    December 31, 2021

    (Date of Event Which Requires Filing of This Statement)

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)


    CUSIP No. 44969Q208 13G Page 2 of 5 Pages

    1 NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

    Rafael Rifat Gabay

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)   ☐
    (b)   ☐

         
    3 SEC USE ONLY
             
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
    Israel

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5 SOLE VOTING POWER
     8,134,185
    6 SHARED VOTING POWER
    1,535
    7 SOLE DISPOSITIVE POWER
     8,134,185
    8 SHARED DISPOSITIVE POWER
    1,535
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     8,135,720

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

    ☐

         
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    11.98%*

    12 TYPE OF REPORTING PERSON*
    IN

    *SEE INSTRUCTIONS BEFORE FILLING OUT!

    * The percentages used herein are calculated based upon 67,838,041 outstanding shares of the Issuer as of November 15, 2021


    CUSIP No. 44969Q208 13G Page 3 of 5 Pages

    Item 1 (a). Name of Issuer:

    IM Cannabis Corp.

    Item 1 (b). Address of Issuer's Principal Executive Offices:

    Kibbutz Glil Yam, Central District, Israel 4690500

    Item 2 (a). Name of Person Filing:

    Rafael Rifat Gabay

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

    Haetrog 83, Moshave Ganot, Israel, 5029300

    Item 2 (c). Citizenship:

    Israel

    Item 2 (d). Title of Class of Securities:

    Common Shares, no par value

    Item 2 (e). CUSIP Number:

    44969Q208

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     (a) ☐ Broker or dealer registered under Section 15 of the Act;

     (b) ☐ Bank as defined in Section 3(a)(6) of the Act;

     (c) ☐ Insurance Company as defined in Section 3(a)(19) of the Act;

     (d) ☐ Investment Company registered under Section 8 of the Investment Company Act;

     (e) ☐ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f) ☐ Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);

     (g) ☐ Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);

     (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:

     (j) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

     ☐ If this statement is filed pursuant to Rule 13d-1(c), check this box.

    Item 4. Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.


    CUSIP No. 44969Q208 13G Page 4 of 5 Pages

     (a) Amount beneficially owned:   8,135,720

     (b) Percent of class:  11.98%

     (c) Number of shares as to which such person has:

     (i) Sole power to vote or to direct the vote:  8,134,185

     (ii) Shared power to vote or to direct the vote:  1,535

     (iii) Sole power to dispose or to direct the disposition of: 8,134,185

     (iv) Shared power to dispose or to direct the disposition of:  1,535

    Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

    Item 5. Ownership of Five Percent or Less of a Class.

    If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     N/A

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     N/A

    Item 8. Identification and Classification of Members of the Group.

     N/A

    Item 9. Notice of Dissolution of Group.

     N/A

    Item 10. Certification. 

     N/A


    CUSIP No. 44969Q208 13G Page 5 of 5 Pages

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

      February 14, 2022
      (Date)
       
       
      /s/ Rafael Rifat Gabay
      Rafael Rifat Gabay


    Get the next $IMCC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IMCC

    DatePrice TargetRatingAnalyst
    10/5/2021$8.00Buy
    ROTH Capital
    7/14/2021Buy
    Desjardins
    7/14/2021$10.50Buy
    Desjardins
    More analyst ratings

    $IMCC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

      TORONTO and GLIL YAM, Israel, May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares ("Shares") from the Canadian Securities Exchange (the "CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC". The Company is entertaining potential transactions that, if completed while the Company is listed on the CSE, would require the Company to incur unnecessary burdensome costs, approvals and delay. The Company believes that the trading volu

      5/28/25 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Provides Corporate Updates

      THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, May 27, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the following corporate updates. Meeting Results Further to its press releases dated Aprill 11, 2025 (the "April 11 Release") and May 7, 2025 (the "May 7 Release"), the Company is pleased to announce results of its annual general and special meeting, held on Friday, May 23, 2025 (the "Meeting"

      5/27/25 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Reports First Quarter Financial Results

      IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel, May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2024, unless otherwise stated. IMC also announces the intention to complete a non-brokered private placement of secured debentures. Q1 2025 Financial Highlights Net profit of $175K94% Gross profit increase vs. Q1 2024 of $3.5M vs. $1.8M and 29% Gr

      5/15/25 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Leadership Updates

    Live Leadership Updates

    See more
    • IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

      TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ --  IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of

      9/11/24 8:30:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

      TORONTO and GLIL YAM, Israel, Oct. 10, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Uri Birenberg will join the company's leadership team as Chief Financial Officer effective October 10, 2023.  This appointment strengthens IMC's financial leadership and strategic direction for achieving sustainable profitability. "We're delighted to welcome Uri as our new Chief Financial Officer at IMC. His impressive track record and extensive experience with large scale international organizations, as well as with startups, make him an outstandin

      10/10/23 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company's Israeli Subsidiary

      Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 13, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany today announced the appointment of Rinat Efrima as the new Chief Executive Officer of IMC Holdings Ltd. ("IMC Holdings"), the Company's wholly-owned Israeli subsidiary. Ms. Efrima will join the Company in the first quarter of 2022. In addition, Ya

      1/13/22 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH Capital initiated coverage on IM Cannabis with a new price target

      ROTH Capital initiated coverage of IM Cannabis with a rating of Buy and set a new price target of $8.00

      10/5/21 7:57:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Desjardins initiated coverage on IMC Mortgage Co

      Desjardins initiated coverage of IMC Mortgage Co with a rating of Buy

      7/14/21 8:40:32 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Desjardins initiated coverage on IM Cannabis with a new price target

      Desjardins initiated coverage of IM Cannabis with a rating of Buy and set a new price target of $10.50

      7/14/21 7:01:53 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Financials

    Live finance-specific insights

    See more
    • IM Cannabis Reports First Quarter Financial Results

      IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel, May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2024, unless otherwise stated. IMC also announces the intention to complete a non-brokered private placement of secured debentures. Q1 2025 Financial Highlights Net profit of $175K94% Gross profit increase vs. Q1 2024 of $3.5M vs. $1.8M and 29% Gr

      5/15/25 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

      TORONTO and GLIL YAM, Israel, May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.     The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a recording of the

      5/6/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

      Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023. The Company's audited consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 and accompanying manage

      3/31/25 8:39:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    SEC Filings

    See more
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/28/25 8:14:12 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/27/25 8:11:41 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/15/25 8:11:48 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by IM Cannabis Corp.

      SC 13G - IM Cannabis Corp. (0001792030) (Subject)

      2/21/23 10:56:41 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by IM Cannabis Corp. (Amendment)

      SC 13D/A - IM Cannabis Corp. (0001792030) (Subject)

      2/8/23 1:29:15 PM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by IM Cannabis Corp. (Amendment)

      SC 13G/A - IM Cannabis Corp. (0001792030) (Subject)

      2/2/23 10:38:01 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care